Literature DB >> 6757888

Prophylaxis for contacts of patients with meningococcal or Haemophilus influenzae type b disease.

E D Shapiro.   

Abstract

The diagnosis of meningitis often causes profound fear and occasionally overt hysteria in family members and acquaintances of affected patients. Recent studies have indicated that in cases of meningitis caused by either Neisseria meningitidis or Haemophilus influenzae type b this fear, at least in part, is justified. Close contacts of patients with either illness are at considerably increased risk of contracting the disease. Consequently physicians are called upon to decide what preventive measures, if any, must be taken. Because prospective controlled studies in nonepidemic periods are difficult to perform, the role of prophylaxis is not entirely clear. Recommendations of experts in the field have been contradictory. This review will attempt to summarize current understanding of secondary spread of these diseases and the role of prophylaxis in their prevention.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6757888     DOI: 10.1097/00006454-198203000-00015

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN: 0277-9730


  4 in total

1.  Chemoprophylaxis for the prevention of bacterial meningitis.

Authors:  U B Schaad
Journal:  Infection       Date:  1984       Impact factor: 3.553

Review 2.  Bacterial meningitis. Rational selection and use of antibacterial drugs.

Authors:  M Whitby; R Finch
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

3.  Bacterial meningitis in children and adolescents: an observational study based on the national surveillance system.

Authors:  Félix O Dickinson; Antonio E Pérez
Journal:  BMC Infect Dis       Date:  2005-11-15       Impact factor: 3.090

4.  Bacterial meningitis in children under 15 years of age in Nepal.

Authors:  Rajani Ghaju Shrestha; Sarmila Tandukar; Shamshul Ansari; Akriti Subedi; Anisha Shrestha; Rekha Poudel; Nabaraj Adhikari; Shital Raj Basnyat; Jeevan Bahadur Sherchand
Journal:  BMC Pediatr       Date:  2015-08-19       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.